Epitope characterization of MUC1 antibodies

被引:20
|
作者
Blockzjil, A [1 ]
Nilsson, K [1 ]
Nilsson, O [1 ]
机构
[1] CanAg Diagnost AB, SE-41455 Gothenburg, Sweden
关键词
MUC1; epitope specificity; CA; 15-3; pepscan analysis; TD-4;
D O I
10.1159/000056504
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The specificities of the 56 MAbs submitted to the ISOBM TD-4 Workshop were characterized by ELISA assays against MUC1-positive (ZR75-1) and MUC1-negative cell lines (LS174T), binding to a 20-mer peptide corresponding to the tandem repeat region of MUC1! apoprotein, and Pepscan analysis of overlapping 9-mer peptides corresponding to the tandem repeat region of MUC1., The recognition of soluble MUC1 antigen from ZR75-1 cell line was also tested in two-site EIA using the ISOBM TD-4 MAb as catching MAb, The studies indicated that 35 of the submitted antibodies recognized epitopes expressed in the MUC1 tandem repeat region, and that 30 of these recognized epitopes within the immunodominant region (PDTRPAP) of the tandem repeat, Recognition of soluble MUC1 from ZR75-1 cell line indicated that additional 10 MAb recognized epitopes 'outside' the tandem repeat region of MUC1 from ZR75-1 cell line, or that the antibodies recognized epitopes depending on the glycosylation of the MUC1 tandem repeat. Six MAbs reacted only with the MUC1-negative cell line LS 174T, and thus most likely did not recognize epitopes specific for MUC1.
引用
收藏
页码:46 / 56
页数:11
相关论文
共 50 条
  • [31] The decision between tolerance and immunity to MUC1 is based on the differences in MUC1 glycosylation
    Ryan, Sean O.
    Wong, Man Yan
    Turner, Michael S.
    Vlad, Anda M.
    Finn, Olivera J.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S265 - S266
  • [32] The production and characterization of novel heavy-chain antibodies against the tandem repeat region of MUC1 mucin
    Rahbarizadeh, F
    Rasaee, MJ
    Forouzandeh, M
    Allameh, A
    Sarrami, R
    Nasiry, H
    Sadeghizadeh, M
    IMMUNOLOGICAL INVESTIGATIONS, 2005, 34 (04) : 431 - 452
  • [33] Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1
    L M Pericleous
    J Richards
    A A Epenetos
    N Courtenay-Luck
    M P Deonarain
    British Journal of Cancer, 2005, 93 : 1257 - 1266
  • [34] Immunoliposomes with single-domain antibodies targeted against mucin 1 (MUC1)
    Bolkestein, M.
    Drabek, D.
    Ten Hagen, T. L. M.
    Grosveld, F. G.
    Koning, G. A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S170 - S170
  • [35] MUC1 and the Immunobiology of Cancer
    Joyce Taylor-Papadimitriou
    Joy M. Burchell
    Timothy Plunkett
    Rosalind Graham
    Isabel Correa
    David Miles
    Michael Smith
    Journal of Mammary Gland Biology and Neoplasia, 2002, 7 : 209 - 221
  • [36] MUC1 expression in plasmacytoma
    Paydas, S
    Sahin, B
    Gönlüsen, G
    Hazar, B
    Zorludemir, S
    LEUKEMIA RESEARCH, 2001, 25 (03) : 221 - 225
  • [37] MUC1 and breast cancer
    Apostolopoulos, V
    Pietersz, GA
    McKenzie, IFC
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 1999, 1 (01) : 98 - 103
  • [38] MUC1, the renaissance molecule
    Gendler, SJ
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2001, 6 (03) : 339 - 353
  • [39] MUC1 in hematological malignancies
    Stroopinsky, Dina
    Kufe, Donald
    Avigan, David
    LEUKEMIA & LYMPHOMA, 2016, 57 (11) : 2489 - 2498
  • [40] MUC1 and endometrial receptivity
    Meseguer, M
    Pellicer, A
    Simón, C
    MOLECULAR HUMAN REPRODUCTION, 1998, 4 (12) : 1089 - 1098